Crucial Functionalizations of Carbon Nanotubes for Improved Drug Delivery: A Valuable Option?
- 14 January 2009
- journal article
- review article
- Published by Springer Nature in Pharmaceutical Research
- Vol. 26 (4) , 746-769
Abstract
Amidst the myriad of Drug Delivery Systems able to enhance delivery, absorption and intracellular uptake of a bioactive molecule while protecting it from deactivation, Carbon Nanotubes (CNTs) have emerged as a recent and promising option especially in cancer therapy. This is mainly due to their unique properties, which render them extremely versatile through the incorporation of several functional groups and targeting molecules at the same time, while their natural shape allows them to selectively penetrate across biological barriers in a non-invasive way. In this expert review we aim to evaluate whether this innovative material, once chemically-modified with suitable functionalizations, can be considered as a valuable system in comparison to the already existing nanodevices. This will include the estimation of the most recent advances in the field of nanotechnology, together with a cautious evaluation of potential risks and hazards associated with the extensive use of this fascinating, but still unknown, nanomaterial.Keywords
This publication has 182 references indexed in Scilit:
- Magnetic nanoparticles with dual functional properties: Drug delivery and magnetic resonance imagingBiomaterials, 2008
- Nanotechnology for breast cancer therapyBiomedical Microdevices, 2008
- Soluble Single-Walled Carbon Nanotubes as Longboat Delivery Systems for Platinum(IV) Anticancer Drug DesignJournal of the American Chemical Society, 2007
- Nano-Bio-Genesis: tracing the rise of nanotechnology and nanobiotechnology as 'big science'Journal of Biomedical Discovery and Collaboration, 2007
- Enhanced Electron-Capture Decay Rate ofEncapsulated inCagesPhysical Review Letters, 2004
- Carotenoid–radical interactionsBiochemical and Biophysical Research Communications, 2003
- Pharmacokinetics of Pegylated Liposomal DoxorubicinClinical Pharmacokinetics, 2003
- Correlative Instrumental Neutron Activation Analysis, Light Microscopy, Transmission Electron Microscopy, and X-ray Microanalysis for Qualitative and Quantitative Detection of Colloidal Gold Spheres in Biological SpecimensMicroscopy and Microanalysis, 1998
- Polyethylenglykol-umhülltes (pegyliertes) liposomales DoxorubicinDrugs, 1997
- Doxorubicin Encapsulated in Liposomes Containing Surface‐Bound Polyethylene Glycol: Pharmacokinetics, Tumor Localization, and Safety in Patients with AIDS‐Related Kaposi's SarcomaThe Journal of Clinical Pharmacology, 1996